Moody’s also affirmed the “A2” rating on the health system’s outstanding bonds.
The ratings affirmations are based on several factors, including the health system’s solid and leading market share position and solid leverage metrics.
The outlook was revised from stable to negative, reflecting Moody’s Investors Service’s unfavorable opinion of the health system’s multiyear trend of challenged operating performance through fiscal year 2017.
More articles on healthcare finance:
AMGA joins provider groups urging CMS to include Medicare Advantage in advanced APM models
Lifespan grows operating income in Q2 as expenses climb
RCM tip of the day: Use data to drive smarter payment plans
